Cargando…
Fialuridine Induces Acute Liver Failure in Chimeric TK-NOG Mice: A Model for Detecting Hepatic Drug Toxicity Prior to Human Testing
BACKGROUND: Seven of 15 clinical trial participants treated with a nucleoside analogue (fialuridine [FIAU]) developed acute liver failure. Five treated participants died, and two required a liver transplant. Preclinical toxicology studies in mice, rats, dogs, and primates did not provide any indicat...
Autores principales: | Xu, Dan, Nishimura, Toshi, Nishimura, Sachiko, Zhang, Haili, Zheng, Ming, Guo, Ying-Ying, Masek, Marylin, Michie, Sara A., Glenn, Jeffrey, Peltz, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988005/ https://www.ncbi.nlm.nih.gov/pubmed/24736310 http://dx.doi.org/10.1371/journal.pmed.1001628 |
Ejemplares similares
-
The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine
por: Jolly, Carol E., et al.
Publicado: (2020) -
The human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG mice
por: Higuchi, Yuichiro, et al.
Publicado: (2014) -
Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism
por: Uehara, Shotaro, et al.
Publicado: (2022) -
Nog kleiner dan quarks
por: Stroeykens, S
Publicado: (1996) -
Nog steeds ‘gewoon’ wetenschap
por: Mulders, Peter F.A.
Publicado: (2021)